Wave Life Sciences, Inc. (WVE)
| Market Cap | 665.47M-53.5% |
| Revenue (ttm) | n/a-30.4% |
| Net Income | n/a-55.9% |
| EPS | n/a-21.1% |
| Shares Out | 197.05M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 805,188.086 |
| Open | 3.45 |
| Previous Close | 3.54 |
| Day's Range | 3.37 - 3.46 |
| 52-Week Range | 3.37 - 21.73 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 13.50(+299.74%) |
| Earnings Date | n/a |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About WVE
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$WVE stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in WVE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by WVE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
WVE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New WVE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to WVE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in WVE
| ETF | Est. Holding Size |
|---|---|
| IWMiShares Russell 2000 ETF | $12.99M |
| VXFVanguard Extended Market ETF | $8.68M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | $6.56M |
| IBBiShares Biotechnology ETF | $4.33M |
| VTWOVanguard Russell 2000 ETF | $3.89M |
| SCHASchwab U.S. Small-Cap ETF | $2.71M |
Estimated from each fund’s disclosed top holdings × AUM
WVE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from WVE’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score